Inizio contenuto principale del sito

Aimo, Alberto; Rapezzi, Claudio; Vergaro, Giuseppe; Giannoni, Alberto; Spini, Valentina; Passino, Claudio; Emdin, Michele

Management of complications of cardiac amyloidosis: 10 questions and answers Open new browser tab

(2021)

Moura, B.; Aimo, A.; Al-Mohammad, A.; Flammer, A.; Barberis, V.; Bayes-Genis, A.; Brunner-La Rocca, H. -P.; Fontes-Carvalho, R.; Grapsa, J.; Hulsmann, M.; Ibrahim, N.; Knackstedt, C.; Januzzi, J. L.; Lapinskas, T.; Sarrias, A.; Matskeplishvili, S.; Meijers, W. C.; Messroghli, D.; Mueller, C.; Pavo, N.; Simonavicius, J.; Teske, A. J.; van Kimmenade, R.; Seferovic, P.; Coats, A. J. S.; Emdin, M.; Richards, A. M.

Integration of imaging and circulating biomarkers in heart failure: a consensus document by the Biomarkers and Imaging Study Groups of the Heart Failure Association of the European Society of Cardiology Open new browser tab

(2021)

Pucci, A.; Aimo, A.; Musetti, V.; Barison, A.; Vergaro, G.; Genovesi, D.; Giorgetti, A.; Masotti, S.; Arzilli, C.; Prontera, C.; Pastormerlo, L. E.; Coceani, M. A.; Ciardetti, M.; Martini, N.; Palmieri, C.; Passino, C.; Rapezzi, C.; Emdin, M.

Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis Open new browser tab

(2021)

Castiglione, V.; Aimo, A.; Vergaro, G.; Saccaro, L.; Passino, C.; Emdin, M.

Biomarkers for the diagnosis and management of heart failure Open new browser tab

(2021)

Castiglione, V.; Franzini, M.; Aimo, A.; Carecci, A.; Lombardi, C. M.; Passino, C.; Rapezzi, C.; Emdin, M.; Vergaro, G.

Use of biomarkers to diagnose and manage cardiac amyloidosis Open new browser tab

(2021)

Nunez, J.; Nunez, E.; Revuelta-Lopez, E.; Minana, G.; Barallat, J.; Bodi, V.; Sanchis, J.; Aimo, A.; Emdin, M.; Lupon, J.; Husser, O.; Bayes-Genis, A.

The influence of sex and body mass index on the association between soluble neprilysin and risk of heart failure hospitalizations Open new browser tab

(2021)

Vergaro, G.; Aimo, A.; Campora, A.; Castiglione, V.; Prontera, C.; Masotti, S.; Musetti, V.; Chianca, M.; Valleggi, A.; Spini, V.; Emdin, M.; Passino, C.

Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure Open new browser tab

(2021)